XTRASEAL Trademark

Trademark Overview


On Wednesday, July 31, 2024, a trademark application was filed for XTRASEAL with the United States Patent and Trademark Office. The USPTO has given the XTRASEAL trademark a serial number of 98675577. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, February 20, 2025. This trademark is owned by Gordon's Medical Inc.. The XTRASEAL trademark is filed in the Medical Instrument Products category with the following description:

Surgical staplers; Surgical staples; Surgical skin staplers
xtraseal

General Information


Serial Number98675577
Word MarkXTRASEAL
Filing DateWednesday, July 31, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, February 20, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the word "XTRASEAL" in stylized font.
Pseudo MarkEXTRA SEAL
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesSurgical staplers; Surgical staples; Surgical skin staplers

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, July 31, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGordon's Medical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOrlando, FL 32819

Trademark Events


Event DateEvent Description
Wednesday, July 31, 2024NEW APPLICATION ENTERED
Saturday, February 15, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 18, 2025ASSIGNED TO EXAMINER
Thursday, February 20, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 20, 2025NON-FINAL ACTION E-MAILED
Thursday, February 20, 2025NON-FINAL ACTION WRITTEN